JSR Life Sciences
Overview
JSR Life Sciences is a life sciences investment firm and operating company that provides integrated solutions, products, and services for drug discovery, development, and bioprocessing, while also maintaining a corporate venture arm to invest in innovative biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Optimeos Life Sciences | Aug 2023 | Seed | Lead |
| Aqualung Therapeutics Corporation | Oct 2022 | Series A | Lead |
| Inhalon Biopharma Inc. | Jun 2022 | Series A | Lead |
| Aqualung Therapeutics Corporation | Jan 2022 | Convertible Debt | Lead |
Key People
Nalini M.
Senior Vice President Of Corporate Development
Paolo Scalzini
Senior Director Corporate Development
Brad Prater
Director
Gerald Platteau
Global Director Technology and Implementation Support
Jared Young
Director, Similis Bio
Kentaro Tamaki
Director of Quality Assurance
Shinya Yamada
Director, Portfolio Management
TOMOHIRO KANEKO
Director, Strategic Planning & Global Coordination
Yuichiro Morimoto
Head of Corporate Strategy and Innovation, Chief of Staff
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
